Company · CIK 0000749647 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Imunon, Inc. · IMNN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 AForm 4 → | Sep 15, 12:43 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 5,824 | $1.47 | $8,561 | 95,699 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 12:42 pm EDT | Stacy LindborgPresident and CEO, Director | 5,504 | $1.47 | $8,091 | 105,580 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 12:41 pm EDT | Douglas Vincent FallerChief Medical Officer | 4,211 | $1.47 | $6,190 | 41,288 | — | |
| Aug 31, 2026 SForm 4 → | Sep 1, 4:06 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,525 | $1.56 | $3,950 | 2,896 | −46.6% | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:10 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 7,371 | $1.60 | $11,794 | 89,875 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:09 pm EDT | Stacy LindborgPresident and CEO, Director | 6,822 | $1.60 | $10,915 | 100,076 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:07 pm EDT | Douglas Vincent FallerChief Medical Officer | 3,626 | $1.60 | $5,802 | 37,077 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:06 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,525 | $1.60 | $4,040 | 5,421 | — | |
| Aug 17, 2026 SForm 4 → | Aug 17, 4:17 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,449 | $1.63 | $3,993 | 2,896 | −45.8% | |
| Aug 14, 2026 AForm 4 → | Aug 17, 4:22 pm EDT | Stacy LindborgPresident and CEO, Director | 6,615 | $1.65 | $10,915 | 93,254 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 4:21 pm EDT | Douglas Vincent FallerChief Medical Officer | 3,516 | $1.65 | $5,801 | 33,451 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 4:21 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 7,147 | $1.65 | $11,793 | 82,504 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 4:17 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,449 | $1.65 | $4,041 | 5,345 | — | |
| Aug 3, 2026 SForm 4 → | Aug 4, 4:13 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,541 | $1.57 | $3,977 | 2,896 | −46.7% | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:17 pm EDT | Christine A PellizzariDirector | 6,934 | $1.59 | $11,025 | 15,076 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:16 pm EDT | James E DentzerDirector | 6,934 | $1.59 | $11,025 | 21,897 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:15 pm EDT | Frederick J. FritzDirector | 6,934 | $1.59 | $11,025 | 21,031 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:14 pm EDT | Donald P BraunDirector | 6,180 | $1.59 | $9,826 | 15,499 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:13 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,541 | $1.59 | $4,040 | 5,437 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:12 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 6,358 | $1.59 | $10,109 | 75,357 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:11 pm EDT | Douglas Vincent FallerChief Medical Officer | 3,649 | $1.59 | $5,802 | 29,935 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:10 pm EDT | Stacy LindborgPresident and CEO, Director | 5,010 | $1.59 | $7,966 | 86,639 | — | |
| Jul 20, 2026 SForm 4 → | Jul 21, 4:15 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,150 | $1.78 | $3,830 | 2,896 | −42.6% | |
| Jul 17, 2026 AForm 4 → | Jul 21, 4:17 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 4,603 | $1.83 | $8,423 | 68,999 | — | |
| Jul 17, 2026 AForm 4 → | Jul 21, 4:15 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,150 | $1.83 | $3,935 | 5,046 | — | |
| Jul 17, 2026 AForm 4 → | Jul 21, 4:15 pm EDT | Douglas Vincent FallerChief Medical Officer | 3,082 | $1.83 | $5,640 | 26,286 | — | |
| Jul 17, 2026 AForm 4 → | Jul 21, 4:14 pm EDT | Stacy LindborgPresident and CEO, Director | 4,907 | $1.83 | $8,980 | 81,629 | — | |
| Jul 6, 2026 SForm 4 → | Jul 7, 4:58 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 920 | $1.88 | $1,730 | 2,896 | −24.1% | |
| Jul 2, 2026 AForm 4 → | Jul 7, 5:05 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 4,410 | $1.91 | $8,423 | 64,396 | — | |
| Jul 2, 2026 AForm 4 → | Jul 7, 4:58 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 920 | $1.91 | $1,757 | 3,816 | — | |
| Jul 2, 2026 AForm 4 → | Jul 7, 4:56 pm EDT | Douglas Vincent FallerChief Medical Officer | 1,308 | $1.91 | $2,498 | 23,204 | — | |
| Jul 2, 2026 AForm 4 → | Jul 7, 4:56 pm EDT | Stacy LindborgPresident and CEO, Director | 2,534 | $1.91 | $4,840 | 76,722 | — | |
| Jun 29, 2026 SForm 4 → | Jun 29, 4:34 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 11,800 | $1.75 | $20,674 | 2,896 | −80.3% | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:35 pm EDT | Douglas Vincent FallerChief Medical Officer | 21,896 | $1.72 | $37,661 | 21,896 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:34 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 14,696 | $1.72 | $25,277 | 14,696 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:22 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 42,519 | $1.72 | $73,133 | 59,986 | — | |
| Jun 25, 2026 AForm 4 → | Jun 29, 4:21 pm EDT | Stacy LindborgPresident and CEO, Director | 67,150 | $1.72 | $115,498 | 74,188 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 7:59 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 4,629 | $1.82 | $8,425 | 17,467 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:17 pm EDT | Stacy LindborgPresident and CEO, Director | 1,803 | $1.82 | $3,281 | 7,038 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 5:15 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 4,089 | $2.06 | $8,423 | 12,838 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 4:14 pm EDT | Stacy LindborgPresident and CEO, Director | 1,593 | $2.06 | $3,282 | 5,235 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.